Suppr超能文献

发酵与人参非发酵对健康韩国志愿者体内人参皂苷代谢物 IH-901 的药代动力学比较。

Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers.

机构信息

Department of Clinical Pharmacology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

出版信息

J Ethnopharmacol. 2012 Jan 31;139(2):664-7. doi: 10.1016/j.jep.2011.11.052. Epub 2011 Dec 9.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

IH-901 (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol) is a novel ginseng saponin metabolite formed by human intestinal bacteria and is known to have antitumor and antimetastatic effects. However, there has been no pharmacokinetic study of IH-901 in human beings.

AIM OF THE STUDY

The aim of this study was to investigate the pharmacokinetic differences of IH-901 from fermented and non-fermented ginseng.

MATERIALS AND METHODS

To investigate whether the pharmacokinetics of IH-901 differ between fermented and non-fermented ginseng, an open label, randomized, single dose, fasting, two-period, cross-over, pharmacokinetic study was conducted. A total of 24 healthy Korean male volunteers participated in this study. All subjects were allocated into two equal groups and administered 3g of fermented or non-fermented Panax ginseng. Serial blood samples for pharmacokinetic analysis were collected in the 24 h after dosing. Plasma IH-901 concentration was measured by a validated high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Pharmacokinetic parameters including AUC(t), C(max), and T(max) were calculated by noncompartmental models in the BA-CALC program (KFDA, 2008, 1.0.0, Korea).

RESULTS

After oral administration of fermented ginseng, 5 subjects experienced diarrhea. The means of AUC(t) and C(max) were significantly different between the two groups. In the fermented ginseng group, AUC(t) was 2083.09±91.97 ng h/mL, a 15.5-fold increase over that of IH-901 from the non-fermented group (134.50±63.10 ng h/mL), and the mean C(max) was 325.00±91.97 ng/mL in the fermented ginseng group, a 27-fold higher value than that in the non-fermented group (13.88±7.24 ng/mL). T(max) was 3.29±1.00 and 12.04±4.96 h in the fermented and non-fermented group, respectively.

CONCLUSIONS

The results of this study showed that the pharmacokinetic parameters of IH-901 from fermented Panax ginseng are different from those of non-fermented ginseng, from which IH-901 is formed by intestinal fermentation.

摘要

ETHNOPHARMACOLOGICAL 相关性: IH-901(20-O-β-D-吡喃葡萄糖基-20(S)-原人参二醇)是一种由人体肠道细菌形成的新型人参皂苷代谢物,已知具有抗肿瘤和抗转移作用。然而,尚未有人体对 IH-901 的药代动力学研究。

研究目的

本研究旨在探讨发酵和非发酵人参中 IH-901 的药代动力学差异。

材料和方法

为了研究 IH-901 从发酵和非发酵人参中的药代动力学是否存在差异,进行了一项开放标签、随机、单剂量、禁食、两周期、交叉、药代动力学研究。共有 24 名健康的韩国男性志愿者参加了这项研究。所有受试者均分为两组,分别给予 3g 发酵或非发酵人参。给药后 24 小时内采集用于药代动力学分析的连续血样。采用经验证的高效液相色谱-串联质谱法(LC-MS/MS)测定血浆 IH-901 浓度。BA-CALC 程序(KFDA,2008,1.0.0,韩国)中的非房室模型计算 AUC(t)、C(max)和 T(max)等药代动力学参数。

结果

口服发酵人参后,5 名受试者出现腹泻。两组间 AUC(t)和 C(max)的平均值存在显著差异。在发酵人参组,AUC(t)为 2083.09±91.97ng h/mL,是未发酵组(134.50±63.10ng h/mL)的 15.5 倍,C(max)平均值为 325.00±91.97ng/mL,是未发酵组的 27 倍(13.88±7.24ng/mL)。发酵组和非发酵组的 T(max)分别为 3.29±1.00 和 12.04±4.96 h。

结论

本研究结果表明,发酵人参中 IH-901 的药代动力学参数与肠道发酵形成 IH-901 的非发酵人参不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验